NCT07898475
In Vitro Susceptibility of Dermatophytes to Terbinafine and Itraconazole: MIC Distributions and Elevated-MIC Isolates in Faisalabad, Pakistan
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Proportion of Trichophyton isolates with elevated terbinafine MIC
Timeframe: Up to 7 weeks after specimen collection
Secondary (4)
Terbinafine MIC distribution, range, MIC50 and MIC90
Itraconazole MIC distribution, range, MIC50 and MIC90
Species distribution of dermatophyte isolates
Association of elevated terbinafine MIC with clinical variables
Arms and interventions
Patients with KOH-confirmed dermatophytosis
Consecutive dermatology outpatients of any age with clinically suspected, KOH-confirmed dermatophytosis. No intervention is given; clinical specimens are cultured and isolates undergo in vitro antifungal susceptibility testing.
Other: In vitro antifungal susceptibility testing
Sites
1 site in 1 country
- Allied Hospital, Faisalabad Medical UniversityFaisalabad, Punjab Province, Pakistan